Human Pangenome: Updating the Reference Sequence
For over two decades, scientists and doctors have relied on a single genetic map to understand what makes us human. This reference sequence was a monumental achievement when it was finalized in 2003, but it had a major flaw: it did not represent the vast diversity of the human species. In 2023, the Human Pangenome Reference Consortium changed biology forever by releasing a new “pangenome.” This update moves away from a linear, single-file map to a complex, multi-path system that better reflects the global population.
The Flaw in the Old Standard (GRCh38)
To understand why the pangenome is necessary, you have to look at what came before. The previous standard, known technically as GRCh38, served as the backbone for genomic research for years. While it was useful, it was severely limited by its source material.
Approximately 70% of the DNA in the old reference came from a single individual. This donor was a man of mixed European and African ancestry living in Buffalo, New York, who volunteered for the Human Genome Project. The remaining 30% came from a handful of other individuals, mostly of European descent.
This created a “reference bias.” If a patient had a genetic variation that did not exist in that one man from Buffalo, genetic tests might flag it as an error or a dangerous mutation, even if it was completely normal for that patient’s ancestry. Because the map was Euro-centric, it made genetic diagnosis less accurate for people of African, Asian, or Indigenous American descent.
What is the Human Pangenome?
The new draft pangenome, published in the journal Nature in May 2023, is not a sequence of a single person. Instead, it combines the genetic material of 47 diverse individuals. This collection of data creates a “graph” rather than a line, allowing scientists to see shared DNA while simultaneously highlighting the unique routes evolution has taken in different populations.
Here are the specific upgrades this new map provides:
- Diversity: The 47 individuals include people from Africa, the Americas, Asia, and Europe. Specifically, 50% of the samples possess African ancestry, roughly 33% are from the Americas (including 6 individuals from the Caribbean), and 13% have Asian ancestry.
- New Data: The pangenome adds 119 million base pairs (the letters A, C, G, and T) that were completely missing from the old reference.
- Structural Variants: It identified 1,115 gene duplications that were previously invisible. These duplications are often critical for understanding how humans evolve and adapt to different environments.
How the Pangenome "Graph" Works
Imagine the old reference genome as a single highway running from New York to Los Angeles. If you drove a different route, the map would say you were “off-road” or lost.
The pangenome functions more like a digital traffic app like Waze or Google Maps. It shows the main highway, but it also displays all the alternate routes, backroads, and detours that different people take to get to the same destination.
In technical terms, this is called a “pangenome graph.” When researchers sequence a patient’s DNA against this graph, they can match the patient’s genetics to the path that fits them best. This eliminates the errors that occurred when trying to force non-European DNA to match a European template.
Medical Breakthroughs and Precision Medicine
The shift to the pangenome is not just an academic exercise; it has immediate implications for healthcare and the development of new medicines.
Diagnosing Rare Diseases
Many rare diseases are caused by variations in regions of the genome that are repetitive or complex. The old map often blurred these areas. The pangenome provides high-resolution clarity. For example, the LPA gene is a major risk factor for heart disease. Because it is highly repetitive, it was difficult to analyze using GRCh38. The pangenome allows doctors to distinguish between harmless and dangerous variants of LPA with much higher accuracy.
Pharmacogenomics
This field studies how a person’s genes affect their response to drugs. Certain populations metabolize medications faster or slower due to variations in the CYP family of genes. Because the pangenome includes data from 47 diverse ancestors, pharmaceutical companies can now design drugs that are safe and effective for a wider range of people, rather than testing them primarily on European genetics.
Improved Cancer Research
Cancer creates chaos in the genome, moving and deleting large chunks of DNA. To understand a tumor, doctors compare it to a “normal” reference. Using the pangenome ensures that the “normal” baseline is actually accurate for the patient’s specific ethnic background, reducing false positives in cancer screening.
The Future: Phase Two and Beyond
The current pangenome is considered a “draft” because the Human Pangenome Reference Consortium (HPRC) is just getting started. The 47 individuals currently in the map were recruited through the 1000 Genomes Project, ensuring strict ethical standards and consent were met.
The HPRC has set a concrete goal to increase this number to 350 individuals by mid-2024. This expansion will focus on underrepresented groups to ensure the map captures the maximum amount of human genetic variation.
Scientists estimate that with 350 individuals, the pangenome will capture nearly all common genetic variation found in the human species. This will effectively end the era of the “single reference” and usher in an age of truly personalized medicine.
Frequently Asked Questions
Is the old reference genome (GRCh38) being deleted? No. GRCh38 is still used for many standard tests and basic research. However, the scientific community is slowly transitioning to the pangenome (GRCh38-based T2T-CHM13 and the HPRC graphs) for complex analyses where diversity matters.
How much did the pangenome cost to build? The National Human Genome Research Institute (NHGRI) has funded the project with approximately $30 million allocated over several years to support the consortium’s work.
Does the pangenome include everyone’s DNA? No. It currently includes 47 people. The goal is to reach 350. It acts as a representative sample of humanity, not a database of every living person.
Will this change my 23andMe or Ancestry results? Eventually, yes. As commercial testing companies adopt the pangenome reference, they will be able to provide much more specific breakdowns of ancestry and health traits for people with non-European backgrounds.